India Panel Pushes Healthcare Reforms to Cut Patient Costs

Medical bills in India are about to get serious attention from lawmakers who want to protect patients from skyrocketing costs.

A parliamentary standing committee just released recommendations that could reshape how Indians pay for healthcare. While the country already regulates medicine and stent prices, diagnostic tests, scans, and imaging services remain completely unregulated, forcing patients to pay wildly different prices for the same tests.

The panel is pushing for a uniform national pricing policy on diagnostics. Right now, only some states occasionally cap test costs, like they did with RT-PCR tests during the pandemic, leaving most patients vulnerable to unpredictable charges.

The committee also wants a separate regulatory body for medical devices, similar to how the Food Safety and Standards Authority independently oversees food safety. The current system treats complex medical equipment like pharmaceuticals, which doesn't fit the industry's unique needs and may be discouraging investment.

Insurance gaps are making things worse. Even patients enrolled in Ayushman Bharat, India's flagship health insurance program, often can't access high-end devices through subsidized channels. The program's reimbursement rates haven't kept pace with actual costs, leaving people to pay significant portions of procedures like cardiac catheterization out of their own pockets.

The committee recommended that Ayushman Bharat package rates get regular updates to reflect real market prices, especially for expensive procedures like cardiac surgery, neurosurgery, and interventional radiology.

The Bright Side

The panel's recommendations go beyond just controlling prices. They're calling for streamlined licensing, reduced clinical trial costs, and a "deemed approval" pathway for devices already cleared by trusted global regulators. This could speed up access to life-saving technology while keeping costs manageable.

The committee also wants penalties for overcharging to go directly back to affected patients rather than government coffers. That means if companies are caught price gouging, consumers would actually see refunds.

To boost domestic manufacturing and reduce dependence on imports, the panel suggested increasing import duties on select devices. This could help Indian manufacturers compete with cheap imports while creating jobs.

The recommendations represent a comprehensive approach to making healthcare more affordable and accessible. If implemented, they could ease the financial burden on millions of Indian families who currently spend significant portions of their income on medical care.

These proposed reforms show that lawmakers are listening to patients struggling with medical costs and taking concrete steps to help.